Tumor‐recruited M2 macrophages can secret CHI3L1 to promote the metastasis of gastric cancer and breast cancer, and elevated serum levels of CHI3L1 glycoprotein are associated with poor prognosis in patients with metastatic breast cancer.26, 27. This evidence concerns the gene CHI3L1 and breast carcinoma.